UroVysionTM testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer

Jared M. Whitson, Anna B. Berry, Peter R. Carroll, Badrinath R. Konety

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'UroVysionTM testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences